Publication
Low carbon projects
Low carbon projects, especially those involving hydrogen and Carbon Capture and Storage (CCS), play a crucial role in the journey towards global decarbonisation.
2022 Guide to Canada’s Pharmaceutical Intellectual Property Regime
Canada | Publication | July 2022
Our 2022 Guide to Canada’s Pharmaceutical Intellectual Property Regime is a convenient all-in-one reference to the important legal and regulatory regimes governing pharmaceuticals in Canada.
The Guide provides a detailed review of the key regimes, including:
- Data protection market exclusivity;
- The Patented Medicines (Notice of Compliance) Regulations (PMNOC), linking generic market access to patent rights;
- Certificate of Supplementary Protection (CSP) exclusivity;
- Biologics; and
- Drug pricing and market access.
We are honoured that the Guide includes a Foreword by our partner, The Right Honourable Brian Mulroney. During his tenure as the 18th Prime Minister of Canada, Mr. Mulroney championed a series of significant legislative reforms to improve protections for pharmaceuticals that continue to operate today. The COVID-19 pandemic has highlighted the importance of fostering investment in research, development and manufacturing by the innovative pharmaceutical industry in Canada. Norton Rose Fulbright’s pharmaceuticals and life sciences team understands the innovative pharmaceutical industry and will continue to work with innovators to defend their rights and maintain the benefits they bring to all Canadians.
We hope this Guide will assist in navigating the complex challenges of this rapidly evolving field.
Recent publications
Publication
Navigating the IPO
Taking your company public is an important milestone, and whilst the landscape for IPOs is complex and dynamic, choosing the right path is essential.
Publication
Essential Corporate News – Week ending 18 July 2025
On 15 July 2025 the Financial Conduct Authority (FCA) published its final rules in relation to reform of the UK prospectus regime (see PS 25/9: New rules for the public offers and admissions to trading regime), largely adopting the approach proposed in its consultation last summer. This is the latest step in the process of reforming the UK’s capital markets, following on from the overhaul of the UK Listing Rules (UKLR) in 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .